Kyle Piskel, Chief Financial Officer at Adaptive Biotechnologies Corp (ADPT), sold 238 shares at $14.05 ($3K) on 2025-11-17, disclosed to the SEC on 2025-11-18.
Seasonal sale ($3k) by Chief Financial Officer — this insider has traded ADPT in November in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| Filing → |
| ADPT | SELL | 2026-02-06 | $40K | — | Filing → |
| ADPT | SELL | 2026-01-14 | $77K | — | Filing → |
| ADPT | SELL | 2025-12-02 | $3.2M | — | Filing → |